B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Introduction: Sepsis is a deadly inflammatory condition that often leads to an immune suppressed state; however, the events leading to this state remain poorly understood. B and T lymphocyte attenuator (BTLA) is an immune-regulatory receptor shown to effectively inhibit CD4+ T-cell function. Therefore, our objectives were to determine: 1) if lymphocyte BTLA expression was altered in critically ill patients and experimentally induced septic mice, 2) whether augmented CD4+ T-cell BTLA expression was associated with poor septic patient outcomes, and 3) if BTLA expression affected the CD4+ T-cell apoptotic cell loss observed in the lymphoid organs of septic mice. Methods: Changes in CD4+ lymphocyte BTLA expression were compared with morbid event development in critically ill ICU patients (11 septic and 28 systemic inflammatory response syndrome subjects). Wild type and BTLA gene deficient mice were utilized to evaluate the expression and role of BTLA in septic lymphocyte apoptotic cell loss. Results: The observed septic ICU patients had a significantly higher percentage of peripheral blood BTLA+ CD4+ lymphocytes compared with critically ill non-septic individuals. Moreover, the non-septic patients with CD4+ T-cells that were greater than 80% BTLA+ were more susceptible to developing nosocomial infections. Additionally, in general, critically ill patients with CD4+ T-cells that were greater than 80% BTLA+ had longer hospital stays. Comparatively, circulating CD4+ T-cell and B-cell BTLA expression increased in septic mice, which associated with the increased septic loss of these cells. Finally, the loss of these cells and cellular apoptosis induction in primary and secondary lymphoid organs were reversed in BTLA deficient mice. Conclusions: An increased BTLA+ CD4+ lymphocyte frequency in the observed critically ill non-septic patients was associated with a subsequent infection; therefore, BTLA may act as a biomarker to help determine nosocomial infection development. Additionally, BTLA expression contributed to primary and secondary lymphoid organ apoptotic cell loss in experimentally septic mice; thus, BTLA-induced apoptotic lymphocyte loss may be a mechanism for increased nosocomial infection risk in critically ill patients. This study had a relatively small human subject cohort; therefore, we feel these findings warrant future studies evaluating the use of BTLA as a critically ill patient nosocomial infection biomarker.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893 · cited 1×
“Co-inhibitory receptors, including programmed death receptor-1 (PD-1), cytotoxic T-lymphocyte antigen-4 (CTLA-4), and BTLA, have also recently gained traction as effective (in the case of anti-CTLA-4; ipilimumab) or potential therapeutic targets in a number of disease states [18,21-23].”
BackgroundBTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology · doi:10.1038/ni944 · Cited by 883 · cited 5×
“Co-inhibitory receptors, including programmed death receptor-1 (PD-1), cytotoxic T-lymphocyte antigen-4 (CTLA-4), and BTLA, have also recently gained traction as effective (in the case of anti-CTLA-4; ipilimumab) or potential therapeutic targets in a number of disease states [18,21-23].”
BackgroundResultInfluentialPD-1 signaling in primary T cells
Riley, J. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00767.x · Cited by 778 · cited 1×
“Co-inhibitory receptors, including programmed death receptor-1 (PD-1), cytotoxic T-lymphocyte antigen-4 (CTLA-4), and BTLA, have also recently gained traction as effective (in the case of anti-CTLA-4; ipilimumab) or potential therapeutic targets in a number of disease states [18,21-23].”
BackgroundDerré, L., Rivals, J.-P., Jandus, C., Pastor, S., Rimoldi, D., Romero, P., Michielin, O., Olive, D., & Speiser, D. E. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40070 · Cited by 295
B and T Lymphocyte Attenuator Tempers Early Infection Immunity
Sun, Y., Brown, N. K., Ruddy, M. J., Miller, M. L., Lee, Y., Wang, Y., Murphy, K. M., Pfeffer, K., Chen, L., Kaye, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801866 · Cited by 51
Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells
Wang, X. ‐., Chen, Y. ‐., Wang, Q., Ge, Y., Dai, Q., Yang, K. ‐., Fang‐Xie, Zhou, Y. ‐., Hu, Y. ‐., Mao, Y. ‐., et al. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00710.x · Cited by 51 · cited 1×
“Alternatively, however, it has been demonstrated that the cross-linking of BTLA on human CD4 T cells leads to an inability to be fully activated (via upregulation of CD25), while also inhibiting their capacity to secrete interleukin-2, interleukin-4, interleukin-10 and interferon-gamma [44], which appears to be consis…”
BackgroundZhang, Z., Xu, X., Lu, J., Zhang, S., Gu, L., Fu, J., Jin, L., Li, H., Zhao, M., Zhang, J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir165 · Cited by 35
Cited by
Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options
Liu, D., Huang, S.-Y., Sun, J.-H., Zhang, H.-C., Cai, Q.-L., Gao, C., Li, L., Cao, J., Xu, F., Zhou, Y., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00422-y · Cited by 607
New insights into the gut as the driver of critical illness and organ failure
Meng, M., Klingensmith, N. J., & Coopersmith, C. M. (2017) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000386 · Cited by 166
Roles of BTLA in Immunity and Immune Disorders
Ning, Z., Liu, K., & Xiong, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654960 · Cited by 157
“Besides, it is further found that critically ill sepsis patients show a markedly increased proportion of BTLA CD4 lymphocytes in peripheral blood, which is associated with a subsequent infection (68).”
BackgroundCheng, T., Bai, J., Chung, C.-S., Chen, Y., Biron, B. M., & Ayala, A. (2016) · Shock · doi:10.1097/shk.0000000000000479 · Cited by 36
Self-citation
Metadata
- Authors
- Shubin, N. J., Monaghan, S. F., Heffernan, D. S., Chung, C.-S., & Ayala, A.
- Venue
- Critical Care
- Published
- 2013-11-29
- Volume
- 17
- Issue
- 6
- Pages
- R276-R276
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W1991180061
- Cited by
- 96
- References
- 7
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients. https://app.cochat.ai/papers/10.1186/cc13131
- The paper
- Shubin, N. J., Monaghan, S. F., Heffernan, D. S., Chung, C.-S., & Ayala, A. (2013). B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients. Critical Care. https://doi.org/10.1186/cc13131
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.